Most Recent
Global pharmaceutical giant Sanofi-Aventis has launched patent infringement proceedings against generic drug maker Alphapharm seeking "urgent interlocutory relief" to prevent a generic injector pen from being listed on the market.
For information on rights and reprints, contact subscriptions@lawyerly.com.au